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ENHANCING DRUG OVERDOSE MORTALITY SURVEILLANCE THROUGH 
NATURAL LANGUAGE PROCESSING AND MACHINE LEARNING 
 
 Epidemiological surveillance is key to monitoring and assessing the health of 
populations. Drug overdose surveillance has become an increasingly important part of 
public health practice as overdose morbidity and mortality has increased due in large part 
to the opioid crisis. Monitoring drug overdose mortality relies on death certificate data, 
which has several limitations including timeliness and the coding structure used to 
identify specific substances that caused death. These limitations stem from the need to 
analyze the free-text cause-of-death sections of the death certificate that are completed by 
the medical certifier during death investigation. Other fields, including clinical sciences, 
have utilized natural language processing (NLP) methods to gain insight from free-text 
data, but thus far, adoption of NLP methods in epidemiological surveillance has been 
limited. Through a narrative review of NLP methods currently used in public health 
surveillance and the integration of two NLP tasks, classification and named entity 
recognition, this dissertation enhances the capabilities of public health practitioners and 
researchers to perform drug overdose mortality surveillance. This dissertation advances 
both surveillance science and public health practice by integrating methods from 
bioinformatics into the surveillance pipeline which provides more timely and increased 
quality overdose mortality surveillance, which is essential to guiding effective public 
health response to the continuing drug overdose epidemic. 
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 In 2019, there was a total of 70,630 overdose deaths in the United States,1 
increasing from 67,367 overdose deaths 2018.2 Drug overdoses continue to be a major 
cause of morbidity and mortality in the United States,2 in large part due to the opioid 
epidemic.3-5 Evidence from morbidity data indicates that the novel coronavirus pandemic 
has led to increased drug overdoses6 in 2020, suggesting that drug overdose outcomes are 
still rising. Identifying and characterizing the burden of the epidemic is critical to 
developing interventions and guiding policy and funding initiatives to combat this public 
health crisis. Epidemiologists and data scientists working at the state, local, and national 
levels use surveillance data to identify regions with high burdens of overdoses, 
demographic subgroups at disproportionate risk of overdose, and substances involved7 in 
causing morbidity and mortality. Mortality surveillance data has highlighted increases in 
deaths caused by drugs such as fentanyl8,9 and psychostimulants.10 
 Evidence from surveillance data is used to guide public health interventions and 
public safety initiatives. To effectively guide practice, surveillance data must be both 
accurate and timely. With the ever-changing landscape of the drug overdose epidemic,4 
timely data is essential. Public health interventions should be targeted to the specific 
substances causing morbidity and mortality in near-real time, not substances that were 
affecting the community in a year prior. Similarly, accurately identifying what substances 
are causing morbidity and mortality is crucial. Public health interventions for prescription 
opioids may consist of increased analysis of prescription drug monitoring program data11 
to identify and stop “doctor shopping”, while an initiative aimed at illicit opioid mortality 
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may focus more on supply-side interventions and harm reduction. Similarly, interventions 
for preventing opioid overdoses may include expanding access to medication for opioid 
use disorder,12,13 while interventions for misuse of methamphetamine, a substance 
causing increased morbidity and mortality during the opioid crisis,10 would include 
increasing access to cognitive behavioral therapy.14 Without timely and accurate 
surveillance data, actionable evidence for the development of public health initiatives will 
be limited. 
 A current barrier in surveillance of drug overdoses is the reliance on death 
certificate data for mortality surveillance. While death certificates contain detailed 
information about the decedent’s demographics and cause- and manner-of-death, death 
certificates often lag behind other surveillance sources due to both the time a death 
investigation takes15 and the process of adding International Classification of Diseases, 
10th Revision (ICD-10)16 codes to the death certificates. Additionally, medical certifiers 
who complete death certificates for drug overdose deaths in some states are not required 
to have a medical background.17 The medical certifier is charged with completing the 
free-text cause-of-death and description-of-injury sections of the death certificate, from 
which information on what substances caused an overdose death is obtained. Data quality 
stemming from errors or misspellings in these sections present additional challenges in 
using death certificate data. For example, the medical certifier may incorrectly spell the 
name of a specific substance, causing the record to be missed when identifying the 
number of overdoses involving that substance.  
 This dissertation aims to address the existing limitations in epidemiological 
analyses relying on death certificate data by enhancing the timeliness and completeness 
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of the information derived from death certificates to advance drug overdose surveillance 
science. The limitations in timeliness and quality both stem from the need to analyze 
free-text data, specifically, the free-text cause-of-death section of the death certificate that 
is completed by the medical certifier during the death investigation. Free-text data can be 
analyzed through the use of natural language processing (NLP) and machine learning 
(ML) methods. NLP and ML have seen extensive use in clinical sciences18,19 but only 
limited use in public health.20 An example of NLP use in other fields include identifying 
drugs from clinical texts,21-23 which could be similarly adopted to identify drugs from 
death certificate text.  
 With the current limitations of death certificate data stemming from the need to 
analyze free-text, leveraging NLP methods is the next step in advancing public health 
surveillance for drug overdose. NLP provides a suite of methods for transforming 
unstructured, free-text data into “features” which can be fed as variables into classical 
statistical methods as well as ML algorithms. NLP typically leads to extremely high 
dimensional data, necessitating ML models capable of handling high dimensionality to 
analyze. In a typical NLP and ML pipeline, data is split into training and testing sections. 
Free-text training data is processed via NLP methods and the created features are fed into 
an ML model that, using these features, are trained to predict some outcome (y). This 
trained algorithm is then deployed onto the test data, predicting the outcome for each 
record in the test data set. The model is then scored based on how well it performed on 
the test data against a gold standard. The final, trained algorithm can then be used on new 
data to predict the outcome when it is unknown or unavailable.   
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The following chapters address three specific aims for developing and integrating 
NLP and ML models in the public health surveillance pipeline for drug overdose 
mortality to advance surveillance science and improve public health practice through 
more timely and accurate surveillance. These aims seek to advance surveillance science 
through the tenets of integration (applying techniques that emerged from a different field 
allows us to uncover new phenomena, linked to previous work in clinical sciences) and 
development (the methods developed in the dissertation are the first of their kind for 
applying NLP to overdose mortality surveillance, and provide a base for researchers to 
build further NLP models for surveillance), defined as two of the five ways in which 
scientific progress is achieved according to the National Research Council.24 
• Aim 1/Chapter 2: Review the existing literature on NLP and ML use in public 
health surveillance to identify current uses and gaps in the literature, 
• Aim 2/Chapter 3: Develop a machine learning model that can identify drug 
overdose deaths through the analysis of free-text to improve the timeliness of 
surveillance data, and 
• Aim 3/Chapter 4: Advance surveillance science by improving the detection and 











Natural language processing and machine learning methods in public health 
surveillance: a narrative review 
 
Introduction 
Public health surveillance (PHS) is the systematic, ongoing collection of health-
related data and its use to assess the health of populations.25 PHS is critical for detecting 
epidemics,26,27 observing long-term health trends,4,28,29 and detecting emerging threats to 
public health.30,31 For example, surveillance of the substance use epidemic has helped 
reveal the rise in fentanyl and its contribution to overdoses in the United States.8,9 
Traditionally, PHS has relied on structured data sources including death 
certificates,5,7,9,28,29,32-35 hospitalization discharge billing data,36,37 disease registries,38,39 
and systems that track specific conditions, such as mandatory reporting databases.40 Each 
has limitations, including timeliness of death certificate data15,41 and lack of specificity in 
the coding structure in hospital billing data.42,43 To address these limitations, PHS has 
begun to increasingly rely on unstructured data sources for surveillance such as free-text 
chief complaint fields from electronic health record (EHR) and emergency department 
data44,45 and narrative text from emergency medical service reports.46-50 
Natural language processing (NLP) and machine learning (ML) methods have 
been developed and applied in clinical sciences51-53 to analyze free-text data. Broadly, 
NLP consists of methods that enable computers to process and analyze human language. 
ML algorithms can be used to develop predictive models using variables (“features”) 
derived from NLP output. In clinical science, NLP and ML tasks typically focus on 
classification (e.g., identifying reportable cancer cases52) or information extraction (e.g., 
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identification of cardiac risk factors54). Using NLP and ML allows researchers to extract 
information without performing lengthy, manual reviews. Relatively recent advances in 
ML, particularly deep learning, the use of neural networks with multiple hidden layers for 
use on complex, feature-rich data,55 have improved the accuracy of NLP methods.56-59 
Compared to relatively common use in clinical science,18,19 NLP and ML have 
been used more rarely in PHS. Increased integration of NLP and ML into PHS activities 
could advance both the science and practice of surveillance by improving capabilities for 
processing bigger, unstructured data.20 Studies examining NLP and ML in PHS have 
been published in a variety of sources, given the cross-disciplinary nature of these 
methods. This narrative review sought to collect peer-reviewed literature that applied 
NLP and ML in PHS and describes the current state of these techniques’ use in the field 
and their current and potential future contribution of NLP to the assessment and science 
of population health. 
 
Methods 
To identify existing literature for this narrative review, PubMed was searched for 
articles containing all of the following terms: (“public health” AND “surveillance” AND 
“machine learning” AND “natural language processing”). When performed in November 
2019, this search resulted in a total of 82 articles. Inclusion criteria consisted of being 
peer-reviewed and describing either the development or application of an NLP method 
that utilizes ML for PHS purposes. No date cutoff was used to exclude articles.  
Of the 82 articles identified, 14 met inclusion criteria. Most of the 68 articles that 
did not meet inclusion criteria were articles that developed NLP and ML methods, but not 
explicitly for PHS; rather, they mentioned that such a method could be used for PHS in 
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their discussion. Additional reasons for exclusion included articles that applied text-
matching methods (such as regular expressions) to analyze text, but did not apply ML 
algorithms. The included articles’ reference lists were searched for additional candidates, 
resulting in the addition of 8 articles for a total of 22 articles included. An abstraction 
form programmed in REDCap was used to guide information abstraction from the 
articles. Abstracted information included year published, purpose and rationale, ML task 
(the formal purpose of the ML model, in NLP typically classification or information 
extraction), training and testing sample size (the number of records used to develop the 
ML algorithm and the number of records used to validate the model, respectively), 
evaluation metrics, score on final evaluation metric, strengths, limitations, and future 
directions noted by the authors. 
 
Results 
Of the 22 articles included in this narrative review, 12 involved traditional data 
sources41,52,60-69 and 10 involved online media data,70-79 summarized in Tables 1 and 2 
respectively. Studies that applied NLP to traditional PHS data covered several health 
conditions, including autism spectrum disorder (ASD),61,69,70,77 drug overdose,41 
cancer,52,60,62,65,66 and infectious diseases.67 Applying NLP and ML addressed different 
challenges in traditional surveillance, including the absence of a defined surveillance 
definition,63 lengthy reviews required to identify cases,61,69 and enhancing the timeliness 
of reporting.41 Most articles that used online media analyzed Twitter (www.twitter.com) 
data; Twitter is a microblogging website where users post “tweets,” messages containing 
up to 280 characters. Challenges addressed by utilizing NLP on online media included 
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monitoring disease activity in near-real time71,72,75,76,78,79 and monitoring conditions that 
are difficult to track typically.70,73,77 
 
Discussion 
Applying Natural Language Processing to Traditional Public Health Data Sources 
Traditional PHS data that were enhanced with NLP and ML included death 
certificate data and emergency department data, including EHRs and pathology reports. 
Several studies utilized NLP and ML to address time lags present in mortality 
surveillance, which relies on International Classification of Diseases, Tenth Revision 
(ICD-10) codes16 for identification of conditions. To eliminate time lag of ICD-10 coding 
for drug overdose mortality surveillance, Ward et al developed a support vector machine 
(SVM) classifier that utilized features from free-text on an individual’s death certificate 
to classify deaths as drug overdose deaths, achieving an F-score80 of 0.97.41 NLP and ML 
methods have been similarly used on death certificates for cancer surveillance.62,65,66 Butt 
and colleagues66 used previously developed named-entity-recognition tools to extract 
features for ML classifiers to identify death certificates as cancer for reporting cancer 
cases, resulting in an F-score of 0.99. This methodology was then extended65 to 
categorize identified cancers’ ICD-10 codes to determine the type of cancer. While their 
analysis achieved high accuracy on common cancers (which made up 85% of all 
cancers), results were lower on rare cancers. This limitation was further addressed62 by 
developing a hybrid ML and rule-based approach, which achieved an overall F-score of 
0.80. 
NLP and ML have also been utilized on mortality data for general 
surveillance.67,68 Koopman and colleagues67 utilized NLP to extract features for an ML 
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classifier that predicts if a death was caused by diabetes, influenza, pneumonia, or HIV, 
achieving an F-score of 0.96, allowing for faster mortality surveillance. Another study 
developed a deep learning architecture to perform ICD-10 coding of death certificates 
from free-text.68 The final model had an accuracy of 0.76, with infrequently occurring 
ICD-10 codes having poor prediction scores. The authors note that sparse modeling 
methods could improve the prediction on these rarer ICD-10 codes. While this analysis 
had relatively low accuracy, the task of coding every ICD-10 code is ambitious. 
PHS utilizing NLP and ML has also been performed for morbidity surveillance 
using EHRs63,64 and pathology reports.52,60 Surveillance of suicide attempts is difficult 
with structured emergency department data. To address this limitation, Metzger et al64 
utilized text from EHRs to develop features for ML classifiers to identify suicide attempt 
visits. This method had an F-score of 0.953, and authors intend to integrate the model 
into national surveillance. Another analysis of EHR data identified adverse drug events 
utilizing named-entity-recognition and relation extraction.63 This analysis compared 
classical ML methods to a more state-of-the-art, long-short-term memory (LSTM) model, 
with the developed SVM outperforming the LSTM (F-score 0.89), providing evidence 
that traditional ML models can still be utilized for PHS over state-of-the-art methods. 
Finally, text from pathology reports were used in conjunction with NLP and ML for 
reporting to cancer registries. Osborne et al52 developed a ML method to classify 
reportable cancer cases among pathology reports, with a maximum entropy model 
attaining an F-score of 0.85, while Alawad and colleagues60 developed a multi-task 
convolutional neural network to extract case information (histological type, cancer cite, 
etc.) required by cancer registries. While the overall scores for this method were not 
10 
 
particularly strong, the study displayed that multi-task convolutional neural networks 
have improved classification performance compared to single-task models, particularly 
for imbalanced data. 
Another application for morbidity surveillance utilized free-text data from the 
Autism and Developmental Disabilities Monitoring network, which are reviewed by 
clinicians to identify ASD cases.69 This is a lengthy process that has led to lagging 
surveillance. In order to address this time lag, Maenner and colleagues69 developed a 
random forest classifier utilizing features from words and phrases from the network’s 
data. Their random forest was trained on 1,162 records from 2008 and tested on 1,450 
records from 2010. Despite this limited training data, their algorithm resulted in an area 
under receiver-operating characteristic curve80 of 0.932. The gold standard method of 
estimating prevalence for ASD results in an estimate of 1.55%, while their ML method 
estimates a prevalence of 1.46%, showing promise for utilizing the method for ASD 
surveillance. Leroy et al61 extended this work by using NLP and ML to extract diagnostic 
criteria for ASD from EHRs; while the evaluation scores were not very high (0.76 and 
0.43 precision and recall scores, respectively) it is clear there is promise for NLP in ASD 
surveillance with additional work needed. 
 
Applying Natural Language Processing to Online Media  
While most analyses of online media utilized social media data,70,72-79 Feldman 
and colleagues71 used news reports to develop a ML classifier to track global infectious 
disease epidemics. Recognizing that media reports often discuss infectious disease 
outbreaks prior to the signal in surveillance systems, their developed algorithm takes 
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news articles that discuss infectious diseases and identifies those that discuss disease 
activity levels. Their ensemble ML model had a final F-score of 0.87, showing potential 
for real-time monitoring of disease activity levels with media reports. Limitations of this 
include potential error in media reports and data is limited by media interest.  
Another study sought to perform PHS on a range of health conditions utilizing 
Twitter data.72 A system called “Crowdbreaks”81 was developed that identifies tweets 
discussing health conditions, then relying on crowdsourcing for annotation. Several built-
in ML models perform surveillance. One task that was explored was performing 
sentiment analysis (classifying a tweet as positive, negative, or neutral) on tweets that 
discussed vaccines, which resulted in precision and recall scores of 0.77. While 
Crowdbreaks is an innovative approach, relying on crowdsourced labels may lead to 
errors in labeling (typically, annotating in studies is performed by multiple trained 
annotators) and a lack of labeled data to train the built-in models. 
Most of the literature that discussed NLP and ML for PHS using social media data 
focused on a specific condition, rather than a range of conditions. To address challenges 
in substance use surveillance, one analysis identified tweets that discuss prescription 
drugs and developed a ML model that identified if the tweet is discussing abuse of the 
prescription.77 This study achieved an F-score of only 0.45 in the highest performing 
SVM, with a relatively small sample size (6,400 tweets). With a larger sample size, state-
of-the-art deep learning models would likely improve classification. Another analysis 
focused on substance use sought to use Twitter and Reddit data to identify individuals to 
target for substance use disorder interventions.70 Reddit (www.reddit.com) is a 
compilation of forums (called “subreddits”) where users can share messages, videos, and 
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other content and have discussions. The classifier developed relied primarily on features 
from lexicons and lookup tables, and as a short report detailed information about the 
modeling strategy is limited. Their final algorithm had an accuracy of 0.90 for identifying 
individuals open to recovery interventions. 
Two other studies utilized Twitter data for maternal and child health surveillance. 
A 2018 analysis identified and characterized tweets discussing birth defects to estimate 
the prevalence of specific birth defects, which are difficult to measure.73 A lexicon and 
rules were developed and bootstrapping methods were used to classify tweets that 
discussed a child with a birth defect and not just discussing birth defects in general. This 
approach resulted in a recall score of 0.95, indicating that expert rules can be utilized 
effectively for text classification. Sarker et al74 sought to identify women who are 
pregnant through user tweets to develop cohort data for drug safety surveillance. Basic 
pattern matching filtered tweets to identify if a user is potentially pregnant, and then 
several ML models were tested utilizing features derived from tweets to determine which 
of the filtered tweets indicated the user is pregnant. Their best performing SVM model 
resulted in an F-score of 0.88, outperforming a neural network.  
One topic that has been extensively explored was the use of Twitter for influenza 
surveillance. A common issue in using Twitter for PHS is filtering tweets that discuss a 
disease but are not talking about an individual having the condition. One analysis 
explored this issue utilizing a two-staged approach of determining if a tweet 1) discusses 
influenza and 2) determining if it is discussing an individual who is infected.78 Their 
method was applied at local and national levels, with counts of ML-model identified 
tweets highly correlated at the week level with counts of influenza-like-illness (ILI) from 
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CDC national surveillance data, but local-level counts not as correlated. Allen et al79 
performed a similar analysis, utilizing an SVM to identify tweets that discussed an 
influenza infection. Their model’s F-score was 0.786, with significant correlation 
between the national ML-model identified rate and the national ILI rate. Similarly to 
Broniatowski et al’s study78 however, regional-level surveillance was less accurate. 
An additional study76 identified if Twitter users misdiagnose themselves with 
influenza to determine if Twitter is a feasible option for influenza surveillance. While 
their study was limited by a small sample size (1,274), the analysis indicated that Twitter 
data incorrectly reports a flu season occurring from late 2011 to early 2012, despite no 
increases in WHO positive influenza counts. A final influenza study75 utilized Twitter 
data to extract topics from tweets that mentioned drugs used to treat influenza. Tweets 
mentioning influenza drugs of interest were identified and then words from the tweet 
were used as features to train ML classifiers that predict if a tweet is indicating 
consumption of the mentioned drug. Their highest performing SVM had an F-score of 
0.82, indicating promise for tracking drug consumption with Twitter. 
A common limitation in studies that use online media is that terminology 
individuals use to indicate health conditions are likely different from medical 
terminology common in PHS. Tweets often contain abbreviations/slang. Additionally, a 
tweet indicating a user has the “flu” may not be discussing influenza at all, as people use 
“flu” to indicate a common cold. These limitations should be addressed as social media is 
used for disease surveillance. Other limitations include private Twitter accounts, whose 
tweets are not available for analysis, and the large samples required for ML models 
which first require annotation. 
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Public Health Implications 
While NLP and ML methods have been used extensively in clinical science to 
analyze free-text data,18,19 they have been used less frequently for PHS despite 
unstructured data becoming more common.20 NLP and ML methods have shown promise 
in studies to enhance surveillance activities, particularly when they focus on a specific 
condition opposed to a variety of conditions,41,62,65,66 but their potential has been largely 
untapped. Further integrating NLP methods into surveillance workflows will advance 
surveillance science and public health practice, with several avenues for advancement 
identified through the review. While Ward et al41 classified deaths as drug overdoses, an 
extension to this method that identifies the drug(s) that caused the death would further 
improve surveillance. Similarly, while detection of cancer-caused deaths had high 
scores,66 there is still opportunity to further improve the classification of rare cancers.62 
New surveillance systems, such as emergency medical services data,44,45 should be 
explored and NLP methods applied to extract information and classify cases.  
There are also gaps in the literature on utilizing social media data for PHS. While 
influenza has been studied relatively extensively,75,76,78,79 there is little literature on other 
infectious diseases. Additionally, given the substance use epidemic occurring in the 
United States, there is opportunity to use social media to track trends related to substance 
use and misuse. Sentiment analysis on tweets that mention specific drugs could create an 
“early warning system” to identify drugs that are rising in use before they appear in 
traditional PHS. 
Overall, most of the literature reviewed utilized traditional ML models opposed to 
deep learning techniques while still achieving high scores. While many of the reviewed 
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articles discussed the development of a process to improve surveillance, some studies 
lacked key information on how these methods were developed. As public health 
researchers begin to use and develop ML models more extensively, care should be taken 
to ensure a thorough description of methods is present in articles, including a step-by-step 
breakdown of the model’s development. For example, common missing details included 
how the model was tuned to select hyperparameter values (cross validation is common 
for traditional methods to avoid overfitting82) and clear indication of whether the training 
and testing data were split to ensure the model is validated on an out-of-sample dataset, 
which could lead to look-ahead bias if it did not occur.83 Table 3 displays facets of ML 
algorithm development that should be included in future research. Another limitation that 
many studies had was sample size. ML models require relatively large amounts of data 
for accurate predictions,84 especially deep learning methods. Finally, most studies 
required manual annotation, which can be a costly, time-consuming process. Contributing 
more resources to manual annotation on PHS data and social media data will be required 
for NLP and ML methods to reach their full potential as a surveillance tool. 
 
Limitations 
A limitation of the narrative review format compared to a structured systematic 
review is that it does not capture detailed information on the number of articles included 
and excluded due to various review criteria, nor does it follow a strict information 
extraction protocol. However, the narrative review format was appropriate for the 
purpose of providing a general overview of the current state of NLP and ML use in PHS 
and identifying future opportunities to use these methods in the field. Another limitation 
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of this review was its narrow search criteria; as a result, some studies that fit the overall 
purpose of this review may have been missed due to the intentionally narrow inclusion 
criteria. Additionally, this review did not examine other text analysis methods (such as 
regular expressions and key word searches) that are more frequently used in PHS for 
analyzing free-text data. A final limitation is that PubMed was the only database 
searched; most if not all articles applying NLP and ML to PHS are likely indexed in 
PubMed, but some candidates may have been missed. As NLP and ML become more 
widely used in PHS, a systematic review of this topic may become warranted. 
 
Conclusions 
While several studies have used NLP and ML methods for PHS, there are 
limitations and gaps that these methods can address. With the increasing size of data and 
unstructured data existing in public health, utilizing NLP and ML methods is essential for 
gaining insights. The overall promise that many studies in this review display indicate 
that NLP and ML have an important place in future PHS. These methods have already 
improved the timeliness of PHS, extracted additional information from data sources, and 
positioned social media as an emerging data source for monitoring disease trends in near-
real time. The continued development and evaluation of these methods will be key to 





Table 1: Articles applying NLP to traditional data sources 
Study Condition(s) Description of method ML Task NLP Task Key Findings 
Butt et al 
(2013) 
Cancer death Classify cancer deaths 
from death certificate 






based features from free-
text 
Traditional ML method was highly 









Develop a ML model 
that predicts if a death is 





Extracting term and 
concept-based features 
from free-text 
These relatively common conditions 
can have classification high accuracy 
with a single model 
Koopman et 
al (2015) 
Cancer death Classify the ICD-10 
codes of cancer deaths 




Extracting term and 
concept-based features 
from free-text 
Common cancers had high accuracy, 
rare cancers had low accuracy 
Osborne et 
al (2016) 
Cancer cases Identify cancer cases 





Extract concept unique 
identifiers from 
pathology reports 
High F-score highlights potential for 











Extracting and stemming 




NLP can be used to classify autism in 
















unique identifiers from 
free-text 
Pilot study had high accuracy, authors 










Develop a deep learning 
model that classifies the 





embeddings for the 
neural network 
Poor prediction scores for infrequently 
occurring ICD-10 codes; models for 
specific conditions are more accurate 
Munkhdalai 




recognition and relation 
extraction, identify 
adverse drug events 









Traditional model outperformed deep 
learning model, indicating that 




Cancer death Develop a hybrid rule-
ML model for increased 
classification accuracy 
of rare cancers 
Multiclass 
classification 
Extracting term and 
concept-based features 
from free-text 
Adding rule-based model to ML 
increases the accuracy of rare cancer 
classification 






criteria for autism 




Extract expressions of 
DSM criteria using a 
lexicon 
Extracting specific criteria for autism is 
a more difficult task than classifying 
the disease 





Classify deaths caused 
by drug overdoses using 




Extract tokens, bigrams, 
and trigrams from free-
text 
Traditional ML methods can be utilized 
for accurate death certificate 
classification of drug overdose 
Alawad et al 
(2020) 
Cancer Extract required case 
information that cancer 




Text pre-processing for 
use in several neural 
networks 
Low accuracy scores overall, but study 
demonstrated promise for multi-task 









Table 2: Articles applying NLP to online media data sources 
Study Condition(s) Description of 
method 
ML Task NLP Task Key Findings 
Broniatowski 
et al (2013) 
Influenza Two-staged 
approach to identify 
Tweets that mention 
influenza and then 
identify if the tweet 







Trends in classified tweets followed 
trends in influenza-like illness 
nationally, with less correlation at the 
local level 





Given a tweet 
discussing a 
prescription drug, 
classify whether or 
not the tweet is 








Developed model has a relatively low 
F-score, but more state-of-the-art 
methods and additional training data 
could improve results 
Mowery 
(2016) 
Influenza Determine if Twitter 
is a feasible source 
for influenza 
surveillance by 
analyzing if users 
misdiagnose 
themselves in tweets 
Binary 
classification 
Extract words and 
bigrams from tweets 
Authors identified a spike in reported 
influenza on Twitter during a period 
without a real spike, suggesting caution 
should be taken when using social 
media for surveillance 
Allen et al 
(2016) 
Influenza Classify tweets that 
discuss an individual 
infected with 






trigrams from tweets 
Identified tweet trends were correlated 
with national and local data, but with 






to normalize tweets 
Kagashe et al 
(2017) 
Influenza Develop a classifier 






Parsing tweets for 
dependency features 
to identify words 
with relations to an 
annotated drug 
Study showed promise for tracking user 
drug consumption through tweets, 
which can be used as a proxy for 
influenza surveillance 
Sarker et al 
(2017) 
Pregnancy Using tweets, 
classify if a Twitter 








of words, extract 
tweet sentiments 
Traditional ML method outperformed 
deep learning, providing evidence 
traditional ML can still be used for 
accurate classification 
Klein et al 
(2018) 
Birth defects Given a tweet 
discussing a birth 
defect, classify 
whether or not the 
tweet is discussing a 









High evaluation scores indicate 
incorporating rule-based methods can 
lead to successful classification for 
surveillance 
Müller et al 
(2019) 
Various Using crowdsourced 
labeling of tweets, 
monitor changes in 











An innovative approach, but using 
crowdsourced labels as opposed to train 
annotators may lead to errors 





articles that discuss 
infectious diseases 
to identify those that 
Binary 
classification 
Extract features from 
news articles for 
supervised ML 
Model has potential for real time 
identification of outbreaks from media 
articles, but is limited by what 












From Reddit posts 
and tweets, identify 
social media users to 
target for substance 







Model developed for Twitter data had 
high accuracy, indicating promise for 

























Table 3: Suggested key elements to be reported in publications reporting results of machine learning models applied in public 
health surveillance 
Topic Checklist items 
Dataset description 
 Time period of data collection 
 Total sample size 
 Training sample size 
 Test sample size  
 How train/test split was performed 
Feature engineering 
 Detailed description of how features included in 
the model were developed, including published 
code if privacy restrictions allow 
Algorithms tested 
 Machine learning models used 
 Describe why these specific models were 
selected 
Training process  Describe how model hyperparameters were selected and any other tuning steps 
Evaluation criteria 
 List the metrics used for evaluation  






Enhancing timeliness of drug overdose mortality surveillance: a machine learning 
approach 
Introduction 
Death certificates (DCs) are the primary source for state and local drug overdose 
(OD) mortality surveillance and are currently the only nationwide source.85 DCs provide 
information about decedents (including demographic information, residence, and place of 
death), cause and manner of death, and substance(s) involved in an OD that are important 
to developing drug OD prevention programs and policies.86,87 In order to design and 
implement effective public health interventions, this information must be available to 
public health practitioners in a timely manner. 
In the case of a suspected drug OD death, a coroner or a medical examiner serving 
the jurisdiction where the death occurred determines the cause-of-death and completes a 
DC.88,89 The DC is then filed (electronically or as a paper copy) with the state office of 
vital statistics (OVS). An electronic record with selected DC fields, including the free 
text information for the cause-of-death,90 is transmitted to the National Center for Health 
Statistics (NCHS) and coded according to the guidelines of the International 
Classification of Diseases, Tenth Revision (ICD-10) to allow standardized classification 
of the causes of death.91-94 A copy of the ICD-10-coded record, containing one 
underlying cause-of-death (UCOD) and up to 20 supplementary causes of death, is sent 
back to the state OVS to be used for epidemiological analysis. There is a significant time 
lag between the day of death and the day when an ICD-10-coded DC record is available 
for identification of a drug OD death (the consensus definition for drug OD mortality 




Y1495,96). Spencer et al. reported that only 37.8% of the drug OD death certificates are 
available to NCHS by 13 weeks (vs. 83.9% for overall deaths), mostly due to delays in 
DC completion related to required forensic toxicology analysis.97 Additional time lag is 
acquired at the NCHS as about two-thirds of the deaths with an UCOD of drug OD are 
coded manually, compared to one-fifth of all-cause deaths.7  
 
Motivation 
Understanding the critical role of surveillance data to inform prevention and 
response to the opioid epidemic, the Centers for Disease Control and Prevention (CDC) 
provided dedicated funding to states to build capacity for more timely and comprehensive 
opioid OD surveillance data.98 This paper examines the feasibility of using natural 
language processing (NLP) and machine-learning (ML) methods to identify potential OD 
deaths from free-text DC fields, allowing the identification of potential drug OD deaths 
(and the initiation of gathering of additional medicolegal data for these cases) before the 
DC records are sent to the NCHS for ICD-10 coding. Figure 1 displays the overall 
workflow of the death investigation and public health surveillance approach; the 
proposed method eliminates the time lag associated with steps 3a-7a, replacing these with 
steps 3b and 4b. We chose NLP and ML as the methodological base given they (a) 
provide an intuitive mapping from free text fields to categories using classification 
techniques and (b) are generally more accurate than rule-based systems in data rich 
settings. Our main goal is to build a practical computational solution that can be 




surveillance with reasonably high accuracy. Hence, all the code used in this effort is 
made publicly available: https://github.com/pjward5656/dcnlp. 
 
NLP and ML Background 
Text is ubiquitous in healthcare and biomedicine coming from different sources 
including biomedical literature (journal articles, conference abstracts), clinical notes (e.g., 
discharge summaries and pathology reports), and social media text (e.g., Twitter, Reddit, 
and specialized forums such as the Cancer Survivors Network). Text classification 
methods from NLP and ML have been shown to play a critical role in health and 
biomedical applications especially when structured sources do not fully capture all the 
information necessary. The NLP component deals with extracting interesting “features” 
(independent variables) based on simple n-grams (typically words and two-to-three word 
phrases) and more involved syntactic constructs such as parts-of-speech for each word 
(e.g. noun, adjective) and constituency and dependency parse trees that represent inter-
word grammatical relations within each sentence. The ML component then learns a 
model with these features as independent variables and the category as the outcome 
variable using, typically, hand-coded training data.  
 
A basic text classification problem typically deals with an outcome variable that is 
binary. For example, based on a pathology report can we identify whether a cancer case 
is reportable or not?52 There could also be cases where the problem is multiclass, where 
one of more than two categories ought to be chosen. For instance, in cancer registries, 




of such sites and this task can be expedited using automated methods.51 A variant of the 
multiclass problem is ordinal classification, where the categories are ordered in some 
manner specific to the task. Although one class is chosen in ordinal models, errors are 
counted differently based on how far away the prediction is from the true category. As an 
example, in psychiatry a recent shared application53 dealt with assigning symptom 
severity categories (absent, mild, moderate, and severe) based on content in a psychiatric 
evaluation note. Finally, multilabel classification handles scenarios where more than one 
category is typically assigned to each input instance. A use-case is when coders assign 
multiple diagnosis codes99 to electronic medical records for every patient visit. For 
elaborate details of specific applications of NLP in biomedicine, please refer to broad 
reviews.100,101 The problem at hand in this current effort is binary classification to identify 




The Kentucky Injury Prevention and Research Center (KIPRC), as bona fide 
agent of the Kentucky Department for Public Health, receives weekly extracts of DCs to 
perform injury surveillance. Coded DCs for years 2017-2018 as of November 1st, 2018 
(n=84,142), were used for this analysis. The ML process requires that the data is split into 
training and testing sets; the coded 2017 DCs (n=48,016) were used as training data and 
the coded 2018 DCs (n=36,126) were used as testing data. In total, 2,478 (2.9%) of the 
DCs were coded as OD deaths based on the ICD-10 code assigned by NCHS in the 
UCOD field.102 These cases were treated as the “true positive” cases when training and 






The task for the ML algorithm in this paper is to take an un-coded DC and 
classify it as an “OD death” or “not OD death” using free-text fields. To automate this 
task free-text fields on the DC were used to create features for a classifier. ML algorithms 
require feature vectors to train the model. In this analysis, a feature is a binary [0,1] 
variable created from an aspect of the free-text present on the DC, and a feature vector is 
z-dimensional vector of features where z is the total number of features.  
 
Feature engineering 
DCs in Kentucky are certified by county coroners or physicians depending on the 
manner of death. The certifier completes the cause-of-death section, consisting of an 
“immediate cause” field (“line a”) followed by three sequential fields indicating 
conditions that were “leading to the cause listed in line a” 7. In addition, the certifier may 
also complete two other sections: 1) “other significant conditions contributing (SCC) to 
death but not resulting in the underlying cause” and 2) “describe how the injury 
occurred.” The latter is only completed if the death resulted from an injury.  
These free-text fields (used by the NCHS to assign ICD-10 codes for underlying 
and contributing causes-of-death) were used to create features for the ML algorithm. Two 
different field combinations were examined for this task: 1) all three free-text sections of 
the death certificate and 2) the cause-of-death section and the description of injury 
section. The latter option was considered as ODs and substance use may not cause death 




section may result in better separation between OD deaths and deaths that involved 
substance use or previous ODs. 
 
Certifiers in Kentucky typically do not write in full sentences using grammatically 
or syntactically correct language when completing the DC. The text is often concise. 
Table 4 shows an example of a typical OD DC. Due to these considerations, to simplify 
the task the fields in the training data were combined into one free-text field. All 
punctuation was removed from this field. Using the scikit-learn103 library in Python, this 
field was tokenized into individual words, bigrams (adjacent two-word sequences), and 
trigrams (adjacent three-word sequences), excluding stop words (“the”, “an”, “and”, etc.). 
All free-text in the data exists in fully capitalized form, and the capitalized tokens were 
used, unaltered, for the analysis. Any token appearing less than five times was discarded. 
The 2017 DC data including the SCC field contained 2,184 unique words and 11,261 
bi/tri-grams. When excluding the SCC field, the word and bi/tri-gram list decreased to 
1,820 and 8,029, respectively. Features for each of these words and phrases were then 
created for the model; a feature was given the value of 1 if the word/phrase it represents 
appeared in the text and a value of 0 otherwise. To illustrate, a feature representing the 
bigram “acute cocaine” would be 1 for the DC in Table 1 while a feature for the word 
“poisoning” would be 0.  
 
Classifiers 
Several classification methods were considered and examined for this task. Linear 




were tested for this classification task. The SVM approach was selected due to both the 
low computational requirements of this method as well as its use in previous, similar 
classification tasks,65-67 while RFs and MLPs were examined as more complex nonlinear 
methods that may identify additional interaction features compared to the linear SVM. 
Figure 2 shows the overall process used to predict if a DC is an OD using only the free-
text fields. While this classification task was implemented in the Python environment, the 
algorithms tested have well documented and easily programmable methods within the 
e1071 and CARET104 packages in R, making this an accessible method. 
 
Training 
The algorithms were trained on all coded 2017 DCs using 3 times repeated, 
stratified 10-fold cross validation within the scikit-learn Python library. Repeated cross 
validation was selected as it is recommended over other methods for general 
classification use.82 Stratified cross validation was used so that each fold created during 
the procedure would have the same makeup of OD deaths and non-OD deaths that the 
entire dataset has (~97% non-OD, ~3% OD) 105. The cost (regularization) hyperparameter 
of the linear SVM, the maximum depth, number of trees, and maximum number of 
features hyperparameters of the RF, and the hidden layer sizes and alpha (regularization) 
hyperparameters of the MLP were tuned based on F-score, the harmonic mean of positive 
predictive value (PPV) and sensitivity.80 F-score was selected as the tuning metric due to 
the class imbalance in the data; tuning based on accuracy would bias the algorithm to 
correctly classifying non-OD cases, as ~97% of the data are not OD deaths. To tune the 




an additional search was performed around the value(s) that the previous step indicated 
was the best value(s) for the hyperparameter(s). This process was repeated subsequent 
times until the ideal hyperparameter value(s) was identified. After this, the entire training 
data was re-trained using the ideal value(s). This tuning approach was implemented as it 
is a straightforward grid-search method commonly used for tuning ML algorithms.106 
 
Testing 
After the learner was trained on the 2017 DC data it was deployed on the 2018 
DC data. The same word/phrase features used in the 2017 DC data were created for the 
2018 DC data. Both free-text field combination algorithms were tested.  
 
Rule-based method 
A final rule-based classification method was also tested for this analysis on the 
2018 DC data. This rule-based method scanned the free text of the DCs for 37 words or 
bigrams that were indicative of an OD death. These words/bigrams were selected from a 
review of OD DCs by epidemiologists with a combined 10 years of experience in OD 
surveillance. For this review, 2017 OD deaths were examined and common tokens 
identified. These words and bigrams are available in Appendix 1. Any DC that contained 
one or more of the words/bigrams in this list were automatically classified as an OD 
death, and any death that did not contain a word/bigram in this list were classified as a 
non-OD death. This rule-based method is a simpler version of previously proposed text-
matching methods,107 and acts as a baseline to compare to the more computationally 






Methods were evaluated based on their performance on the test data. To compare 
the results of the methods the F-score was calculated along with sensitivity and PPV. For 
this task PPV was considered the most important metric, as large numbers of false 
positives could be problematic when attempting to develop near real-time interventions 
for an OD outbreak. Two-proportion z-tests were performed to test for statistically 
significant differences between the sensitivity and PPV of the best performing ML model 
and rule-based method. 
 
Results 
The model including all three sections had a total of 13,445 features while the 
model excluding the SCC section had a total of 9,849 features. Computing time for 
training the ML models was not significant; even when using stratified 10-fold, 3 times 
repeated cross validation the longest any model took to train was roughly ~3 hours on a 
Windows machine with 32 GB of RAM. Deploying the models on the 2018 data took 
seconds. The rule-based method does not involve any training and produced predictions 
instantly.  
Table 5 displays the F-score, sensitivity, and PPV from the final methods when 
training the models with features constructed from all three sections and Table 6 displays 
the results when training the models with features from the cause-of-death and 
description of injury sections. All of the models were highly specific. Only ~3% of all 
deaths in the data were OD deaths and all of the ML models had high performance in 




however, all performed equally or higher than their counterpart ML models with the SCC 
section with regards to sensitivity, PPV, and F-score. The SVM model without the SCC 
section was the best performing model overall, with an F-score of 0.9695, and also 
achieved the highest PPV (0.9622), while the RF model without the SCC section 
achieved the highest sensitivity (0.9803). Table 7 displays the confusion matrix for the 
SVM excluding the SCC section while Table 8 displays the confusion matrix for the rule-
based model excluding the SCC section. 
The rule-based models did not perform as well as their counterpart ML models. 
The rule-based model excluding the SCC section had similar PPV to the ML models 
(0.9504), however this model had lower sensitivity than the ML models (0.9243). The 
rule-based model excluding the SCC section had a higher F-score than the rule based 
model including this section, similar to the results of the ML models. Comparing the best 
performing ML model (SVM, Table 6) to the best performing rule-based model (Rule-
based, Table 6), two-proportion single-tailed z-tests show that the ML model has a 




This paper presents an accessible method to quickly identify OD deaths from free-
text DCs for rapid surveillance purposes. The performance of the ML algorithms 
developed were very high. The F-score of 0.9695 for the best performing model is 
comparable, and in some cases superior, to that of other models for cause-of-death 
classification in the literature,65-68,108 many of which were trained on larger datasets with 




rule-based models, including significantly higher results for sensitivity, providing 
evidence for further increasing the use of ML in public health surveillance over more 
traditional methods.  
Of the methods compared, the ML models that excluded the SCC section 
produced the best performing models, as the ML models that included all three sections 
had more false positives than their counterpart models. This is likely because features that 
identify an OD death when appearing in the description of injury section or the cause-of-
death section have different meaning in the SCC section. For example, the bigram “drug 
overdose” clearly indicates the death was caused by an OD when present in the cause-of-
death section, but when present in the SCC section may indicate that the individual had a 
previous OD event, but it did not directly lead to death. Including the SCC section results 
in a feature space that contains information that is not directly involved in causing death, 
leading to a slightly biased model. Further research should examine including the SCC 
section in a classifier to identify drug-related deaths, which are important for drug-related 
surveillance. 
 
Public health implications 
DC data is the only national source for OD mortality surveillance85 and as such is 
extremely important for understanding the opioid epidemic and developing responses to 
it. These data, however, comes at a non-trivial time lag7,97 that prohibit availability of 
actionable data until several weeks following the event of an OD death. The method 
proposed in the present study eliminates the time lag from transferring DCs between the 




state or local jurisdictions to process their own mortality data as soon as the DC is 
available in their database with free-text cause-of-death information. This provides more 
timely provisional counts for OD deaths, allowing for detection of overdose death spikes 
and identification of new patterns in contributing drugs in a shorter time window, which 
could be key as novel designer drugs emerge.3,8,109 This could lead to faster mobilization 
of community stakeholders to implement harm reduction strategies, such as targeted 
naloxone distribution to communities. 
An additional application of the ML method developed is its potential use as a 
data quality instrument. While many OD deaths are manually coded at NCHS,7 there is 
still the potential for coding errors to occur. Records that the classifier identifies as OD 
deaths but NCHS codes as non-OD deaths (false positives) can be reviewed by a medical 
examiner to determine if the case is truly a false positive or if the UCOD was coded 
incorrectly. This data quality process will capture OD deaths that previously were not 
identified and lead to more accurate, complete surveillance of the OD epidemic. 
 
Future directions 
To further improve this model, additional feature engineering could be explored. 
This could include adding regular expression features to the model to identify patterns 
that frequently appear on OD DCs. Additionally, more n-gram features (such as non-
adjacent bigrams) could be added to the model. Features that do not arise from NLP that 
use other fields on the DC (demographics, manner of death, place of death, etc.) could 
also be exploited in a future classifier. Part-of-speech tagging and dependency parsing, 




words in sentences,110 was considered for generating additional features for this analysis. 
Likely because the free-text present on DCs is often not grammatically correct, these 
features did not significantly increase the predictive power of the models. To build a 
simpler model they were excluded from the final analysis. 
Deep neural networks, specifically convolutional neural networks, were 
considered for use in this task as they have been used for classifying free-text DCs.68,108 
Due to the small amount of text present on DCs (some contain only two words) a 
traditional classification method was selected in our effort. Future research should 
examine deep learning methods (particularly the use of pre-trained word embeddings) 
and determine if they have higher performance for this task. In general, however, 
improving performance scores that are already in the high nineties (our F-score was 
0.9695) will be a challenging endeavor that is worth further exploration. Deep learning 
should also be explored in the future for more complicated DC classification tasks, 
particularly multilabel classification of the substances that caused a drug OD death. An 
OD DC may contain no information about the substances causing the drug OD or list 
several substances involved in the death. A deep learning framework that can classify 
drug OD deaths and the substances causing the death from DC free-text would be a 
noteworthy extension to the methods developed in the present study. Since the 
completion of postmortem toxicology alone can delay the completion of the DC for 
weeks, the next step for improved timeliness in OD death surveillance is to expand the 
proposed machine learning models to work directly on medicolegal death investigation 
data, utilizing unstructured data from coroner and medical examiner case management 




notes) thus identifying likely drug overdose cases before the DC is officially filed. As 
these reports typically contain much more free-text than DCs, deep learning models 
should be explored for this process as well.  
 
Strengths and limitations 
The present study has several strengths. A thorough literature review indicates 
that this is the first study of its kind to our knowledge to describe a method for classifying 
OD deaths from free-text DCs using NLP and ML. The design of this experiment mimics 
how the model would be applied in a real-life use case scenario, with features engineered 
from previous year(s) data exploited to classify new data, giving the metrics on the test 
data validity for future use. This setup also adds to the difficulty of the task, as new 
substances that may be important in drug OD classification in a future year may not be 
present in the past year that the algorithm was trained on. Despite this, the ML models 
excluding the SCC field all achieved F-scores above 0.96.  
Another strength of this study is the availability of data for our models to be 
tested on, further research to be performed, and similar algorithms to be developed. A 
major limitation of most ML applications is the large amounts of training data needed 
which coincides with the long, tedious process of labeling training data. Previous years 
coded DCs, however, are readily available for training at most state’s health departments. 
These DCs are ready to be used for training ML models without the typical initial 
requirement of labeling. This labeled data, while not publically available, can be 
requested from states’ OVS for research purposes. In addition, the NCHS operates the 




the NCHS made available to researchers a Redacted Death Certificate Literal Text File 
(LTF)111 that includes the cause-of-death text record for every U.S. resident death. The 
access to LTF will allow researchers to test our GitHub source code on DC records that 
come from all U.S. jurisdictions. 
The study has some limitations. First, the models were trained on only Kentucky 
DCs, meaning that the model may not perform as well on data from other jurisdictions if 
certifiers use different words or phrases on their DCs. Kentucky, however, has a hybrid-
coroner/medical examiner system with 120 county coroners and deputy coroners who 
certify deaths (per KRS 72.025) along with medical examiners who assist coroners in 
determining the cause and manner of deaths.112 Physicians also certify natural deaths. 
Therefore, there is a diverse group of individuals certifying deaths in Kentucky, meaning 
the language on Kentucky DCs represents a range of medical backgrounds. Another 
limitation, inherent in ML, is the difficulty in diagnosing errors. The models described 
here have features numbering near the 10,000s—determining exactly what features are 
causing the model to incorrectly predict is inherently more difficult than for a simpler 
model with a small number of variables. A detailed error analysis of the SVM model 
excluding the SCC field is available in Appendix 2. 
 
Conclusion 
The present study compares three methods for identifying OD deaths from free-
text DCs using NLP and several ML models as well as a simple rule-based method. 
Classifying OD deaths using free-text would substantially reduce the time it currently 
takes a surveillance systems to identify OD deaths, from several months to a few weeks. 




providing evidence that ML methods should be implemented in public health surveillance 
tasks, particularly for OD mortality surveillance. The programming code used to develop 
the model is publically available, which can facilitate further testing and development in 
other jurisdictions. Further research is needed to explore the potential for other causes of 
death to be classified using ML methods as well as additional exploration of ML, 







































Table 4: Example Death Certificate Free Text 
Field Text  
Immediate cause-of-death ACUTE COCAINE TOXICITY 
Due to (or as a consequence of)  
Due to (or as a consequence of)  




























Table 5: Final model results on test data, features from all death certificate sections 
Method PPV Sensitivity F-score 
SVM 0.9549 0.9748 0.9647 
RF 0.9328 0.9748 0.9533 
MLP 0.9518 0.9737 0.9626 
























Table 6: Final model results on test data, features from cause-of-death and 
description of injury fields 
Method PPV Sensitivity F-score 
SVM 0.9622 0.9770 0.9695 
RF 0.9531 0.9803 0.9665 
MLP 0.9621 0.9737 0.9678 
























Table 7: Confusion matrix, SVM model, features from cause-of-death and 
description of injury fields 
  UCOD Label  
  Drug OD Not Drug OD Totals 
Predicted 
Label 
Drug OD 891 35 926 
Not Drug OD 21 35,179 35,200 
























Table 8: Confusion matrix, rule-base model, features from cause-of-death and 
description of injury fields 
  UCOD Label  
  Drug OD Not Drug OD Totals 
Predicted 
Label 
Drug OD 843 44 887 
Not Drug OD 69 35,170 35,239 

























Deep neural networks for fine-grained surveillance of overdose mortality  
 
Introduction 
Death certificates (DCs) are the primary data source for drug overdose (OD) 
mortality surveillance, providing information about the cause- and manner-of-death.2,5 
Medical certifiers write the cause-of-death in free-text fields on the DC,7,113 which are 
then used to assign International Classification of Diseases, 10th Revision16 (ICD-10) 
codes by the National Center for Health Statistics (NCHS) to each death certificate.  ICD-
10 codes are used at the national and local levels to calculate OD mortality statistics, to 
monitor trends in the drugs involved in overdoses, and for epidemiological analyses. 
Specifically, ICD-10 codes assigned as an underlying cause-of-death are used to identify 
drug OD deaths and those assigned as supplemental cause-of-death codes (up to 20) are 
used to identify the drug(s) involved in the OD.2,7,102 This process is central to the 
surveillance of drug OD mortality and is the primary way in which OD mortality 
information is reported to communities. 
The ICD-10 classification process of drug overdose deaths (also called drug 
poisoning in the ICD-10 terminology) has limitations, however, including timeliness of 
data,7,15 and the lack of fine-grained granularity in the coding structure of ICD-10 for 
identification of specific drugs contributing to an overdose death.114 Some drugs have 
specific codes (e.g., T40.1 indicates heroin involvement, T40.3 indicates methadone 
involvement), but other drugs of interest do not. For example, ICD-10 code T43.6 
specifies poisoning by “psychostimulants with abuse potential10”, which includes illicit 





prescription amphetamine but excludes the psychostimulant cocaine, which has its own 
ICD-10 code (T40.5).10 ICD-10 code T40.4 specifies “synthetic narcotics5”, which 
includes fentanyl (prescribed or illicitly manufactured) and fentanyl analogs that have 
been a major cause of drug OD deaths in the United States,4,8,9 but also prescription drugs 
like tramadol. 
This inexhaustive coding structure of ICD-10 has led epidemiologists at the 
national and local levels to rely on text analyses to identify specific drugs involved in OD 
deaths when the codes present are not indicative of a specific drug. In 2015, the Council 
of State and Territorial Epidemiologists (CSTE) released a tool to identify specific drug 
mentions from the free-text cause-of-death section of DCs.115 This tool consisted of a 
SAS program115 that looped through individual words in the cause-of-death section and 
matched the words to a lookup table containing search terms (dug names, metabolites, 
and common misspellings) and a crosswalk to a referent drug. The tool produced a list of 
drugs found in each record. In 2016, the NCHS developed a methodology for identifying 
specific drug involvement from the cause-of-death section that again relied on a lookup-
table.7 This methodology additionally considered contextual information and had a more 
extensive table than the CSTE tool. While these tools presented improvements over using 
ICD-10 codes alone, they were limited by their respective lookup tables, requiring 
frequent updates with novel drugs. Additionally, maintaining every possible misspelling 
or metabolite for substances is a difficult, ongoing, and resource-intensive task. 
Modern approaches within the field of natural language processing (NLP), 
including named entity recognition (NER),116 could be applied in the area of drug 





deaths before the ICD-10 coding of the death certificates is completed; and 2) improve 
the identification of specific drug involvement by identifying drug search terms that are 
missing in the lookup tables.  
NER involves tagging particular words as “named entities” (e.g., relevant to 
overdoses, tagging substance names, misspellings, metabolites, and generics as “drug 
entities”) and then training a machine learning (ML) algorithm to identify these entities 
from free-text. This allows for the trained algorithm to predict what word(s) on new DC 
records are drug entities.22,23,117 
Modern NER techniques leverage deep learning21,117-119 methods that involve 
artificial neural networks with several hidden layers. This allows for the model to 
automatically learn complex and robust features that are predictive of outcomes based on 
textual inputs.120 Manual feature engineering that was the hallmark of traditional NLP 
methods gave way to dense neural representations that have been shown to be more 
powerful in information extraction applications, including our current task. An advantage 
of this approach is that NER does not rely on a lookup table to determine which word(s) 
are indicative of a substance, rather, the ML algorithm through training learns which 
words (and surrounding contexts) are indicative of substances. NER has been extensively 
used in clinical science to identify substances in free-text,21-23,117,121 but has not been 
utilized for DCs to our knowledge.   
The present study sought to advance the science and practice of drug OD 
mortality surveillance through the development of a modern NER tool for identifying 
substances on drug OD DCs. Integrating NER methods into the drug OD mortality 





health practice by improving the granularity and timeliness of OD mortality surveillance. 
This study demonstrates how the adaptation of the NER methodology enhances the 
current public health surveillance practice of identification of specific drug involvement 




Data for this study was extracted from the Kentucky Death Certificate Database, 
Kentucky Office of Vital Statistics, Department of Public Health on March 9th, 2020. All 
records coded with the consensus definition for drug OD death2 for years 2014-2019 
were identified and pulled from the database, resulting in a total of n=8,146 OD DC 
records used to develop the NER drug identification tool. Using R,122 the free-text data 
was parsed and reshaped so that every row was one individual element of the free-text 
from the cause-of-death section. To demonstrate, a DC that said “HEROIN, 
FENTANYL, AND OXYCODONE OVERDOSE” was transformed into 7 rows (one for 
each token), corresponding to the elements “HEROIN”, “,”, “FENTANYL”, “,”, “AND”, 
“OXYCODONE”, “OVERDOSE”. This process resulted in a dataset with 95,566 total 




To tag the individual words as drug entities, the dataset was split in half. Two 
trained annotators labeled each split according to the beginning, inside, last, outside, unit 





entity is tagged as “U-entity” (unit). An entity that spans numerous tokens is tagged with 
“B-entity” (beginning), “I-entity” (inside), and “L-entity” (last), for the first token in the 
entity, any tokens between the first and last tokens in the entity, and the last token in the 
entity, respectively. Any words that do not represent an entity of interest are tagged with 
“O” (outside). Table 9 shows how a record annotated with the BILOU scheme looks for 
drug entities. Kappa statistics were calculated for each split and for the entire dataset. 
Any disagreements between annotators were identified and resolved at meetings of all 
four annotators to produce the final, annotated dataset.  
 
NER Drug Identification Tool and Modeling strategy 
Development of the NER tool utilized the Flair124 library in Python. Flair is a 
flexible, powerful NLP library that provides a suite of word embeddings125 in addition to 
an easy to navigate modeling framework for programming deep neural networks for NLP 
tasks, including NER. Word embeddings are semantic vector-space representations of 
words. In a typical embedding setting, words that are closely related have similar vector 
representations, which provides a more desirable quality for word-representation in NLP 
tasks compared to simple dictionary-key representations. The Flair library provides both 
previously developed embeddings (such as GloVe125) as well as Flair embeddings,124 
which were developed using a character-level recurrent neural model that is 
contextualized by surrounding text, meaning an individual word can have multiple 
embeddings depending on the context. More recently, Flair embeddings were extended to 
“pooled Flair embeddings,126” which addresses the limitation of producing useful 





In general, development of a model in the Flair framework follows the following 
steps: 1) labeled corpus creation, consisting of creating a train-test-validation split and 
pre-processing data to fit into Flair’s framework; 2) choosing word embeddings; 3) 
selecting a model; 4) training the chosen model using the selected embeddings. For the 
present study, two models were developed using this framework, only differing in step 2. 
The n=8,146 DCs were split into training (n=6,108), validation (n=816), and test 
(n=1,222 DCs) sets, roughly a 75%-10%-15% split, respectively. This split was 
performed chronologically; DC records were sorted by date of death, and the first 75% 
were assigned to the training data, the next 10% were assigned to the validation data, and 
the final 15% were assigned to the test data. For word embeddings, a model with GloVe 
embeddings was developed as well as a model using forwards- and backwards-trained 
pooled Flair embeddings. Hypothetically, the contextual Flair embeddings should out-
perform GloVe. Testing the pooled embeddings was of interest as DC text contains 
frequent misspellings as well as rare words such as metabolites of drugs and novel 
substances. The model development pipeline is displayed in Figure 3. 
The modeling framework selected was a bidirectional long-short-term memory 
(BiLSTM) conditional random field (CRF) model. BiLSTM-CRF was selected as it 
achieved state-of-the-art performance in NER tasks previously.119 Flair has a BiLSTM-
CRF model built into the library, which utilizes the PyTorch framework.127 For training, 
the model was set to run for 150 epochs. After each epoch, the model was tested on the 
validation set and the model’s accuracy was calculated. The highest-scoring model on the 
validation set was saved during training and deployed on the test data. Documented code 





and F-score (harmonic mean of PPV and sensitivity)80 were calculated for each models’ 
performance on the test set for evaluation. High PPV indicates that there are few false 
positives; a PPV of 90% means that 9 out of every 10 entities the model identifies as drug 
entities are truly drug entities. In this example, the false positive rate is 10%. High 
sensitivity indicates that there are few false negatives; a sensitivity of 90% means that 9 
out of every 10 tokens that are truly drug entities are correctly identified as drug entities. 
In this example, the false negative rate is 10%. F-score provides one score to directly 
compare competing models. To demonstrate the advantage of the deep learning approach 
over traditional machine learning methods, a Naïve Bayes model was also developed 
using a dictionary-key representation for words and evaluated on the test data for a 
baseline comparison. 
 
Comparison to lookup table approach 
A widely used methodology for identification of specific drug involvement is 
based on literal text search for drug names, metabolites, and misspellings, cross-walked 
to a “referent drug” and included in a lookup table of search terms. The methodology was 
described and implemented in a CSTE tool115 in 2015. The Kentucky Drug Overdose 
Fatality Surveillance System32 has been updating the initial CSTE dictionary, and the 
current table includes more than 250 referent drugs (Appendix 4). To determine if the 
NER model provides an improvement over current methods, the lookup table approach 
was used to identify drug entities on the test data. Unlike the neural NER model 
developed, the lookup table approach has no false positives (as any word identified from 





performing BiLSTM-CRF identified that the lookup table did not was calculated to 





The dataset had a total of n=95,566 tokens that required annotation and each 
token needed to be assigned a BILOU tag as discussed in the Methods. The kappa 
statistic between the first two annotators (first half of the dataset) was 0.996 and between 
the second two annotators (second half of the dataset) 0.973. Overall, the entire dataset 
after annotation had a kappa statistic of 0.983. The kappa values indicate the annotation 
task resulted in “perfect” inter-rater agreement level as per suggested rule of thumb129 
making it a very high-quality dataset. 
 
Modeling 
Table 10 displays the results from the respective BiLSTM-CRF models with the 
basic GloVe embeddings and Flair embeddings as well as the results from the Naïve 
Bayes model. While both deep learning models achieved considerably high performance 
for this task, the model utilizing pooled Flair embeddings performed better, with both 
fewer false positives and false negatives, resulting in higher scores for Flair vs GloVe for 
PPV (99.16% vs  98.63% ), sensitivity (99.10% vs 98.08%) and F-score (99.13% vs 
98.35%). Both deep learning models achieved substantially higher scores than the 
baseline Naïve Bayes model (F-score=15.58%). Figure 4 displays the validation loss 





The BiLSTM-CRF model using pooled Flair embeddings was able to recognize 
drug entities that the lookup table was not. In total, the deep learning approach identified 
168 more entities than the lookup table did. Appendix 5 displays the 130 unique drug 
search terms that the lookup table did not contain that were present in the test data. Many 
of these entities were terms that spanned multiple tokens, such as “DESIGNER 
OPIOIDS”. While the lookup table had the term “OPIOIDS”, the deep learning method 
identified the entity “DESIGNER OPIOIDS”, which provides more information on the 
specific drug than the term “OPIOIDS” alone. Other missed entities included 
misspellings, such as “OXMORPHONE”, “ALPRAZOLM”, and 
“METHAMPHETTAMINE”, which all have the correctly spelled terms in the lookup 
table but not these specific misspellings. Table 11 displays 3 example death certificate 
records and shows the entities identified by each approach. By contrast, there 13 
instances where the opposite occurred, in which the lookup table identified a drug entity 




This study presents a highly accurate method for identifying drug entities on free-
text drug OD DCs utilizing a modern NLP model. The F-score of 99.13% for identifying 
drug entities achieved in the present study show significant promise for using deep 
learning methods in public health surveillance. The BiLSTM-CRF model leveraging 
pooled Flair embeddings also identified substantially more drug entities than the current 





an improvement over currently available surveillance tools. In total, the best deep 
learning approach identified 130 new unique drug entities compared to the lookup table. 
During training, the model achieved lower (better) loss on the validation data than 
the training data, as displayed in Figure 4. This is an unexpected result, as typically 
models will have higher scores on the in-sample training data than the out-of-sample 
validation set. Potential reasons for this include the relatively small sample size of the 
validation set (n=816) compared to the training set (n=6,108). Additionally, it is possible 
that the training data contained more difficult examples for the model to categorize than 
the validation data. A practical reason for this is how the data was split; the training data 
includes the oldest (chronologically) DC records. In Kentucky, public health initiatives 
have worked with medical certifiers to improve DC completion and accuracy for drug 
overdose deaths, so DCs completed earlier in the epidemic may be of lower quality and 
thus more difficult for the model to learn than more recent DCs. 
 
Implications for public health practice 
While knowledge of deep learning methods and NER is not typically part of a 
public health practitioner’s toolkit, epidemiologists working in OD surveillance possess 
knowledge of programming and text analytic tools as they have become required for 
identifying drugs that cause morbidity and mortality in communities.7 The high 
performance achieved by the developed model shows that deep learning should be 
leveraged moving forward in public health practice as a tool to solve challenges that 
appear in free-text data. Epidemiologists working at the state, local, and national levels 





public health practice and improve surveillance data quality. Neural NLP methods will 
become essential as public health surveillance continues using more data sources that 
contain free-text, including electronic health records,40,49,61,64 emergency medical services 
run data,44,45,130,131 and syndromic surveillance,27,46,48,132 which are used for both drug 
ODs and other health conditions.  
As many jurisdictions performing OD mortality surveillance will not have the 
expertise nor the computational power to develop and test NLP models, the developed 
model can advance surveillance efforts through improvement of the current surveillance 
pipeline. In analysis of Kentucky data alone, the deep learning model identified over 100 
unique drug entities that a lookup table did not contain. Identified entities can be 
extracted from the model’s results and added to the lookup tables of current tools, which 
can be disseminated to jurisdictions to improve identification of specific drugs. This will 
allow for the increased specificity of drug entities that the model provides without 
needing to run a complex model in situations where computational power or expertise is 
limited. With periodic runs on a fresh set of DCs, our model can thus surface new drug 
terms and improve operations in jurisdictions that do not necessarily have the resources 
to train and deploy neural models.  
Integration of additional entities recognized by the model into existing tools in the 
drug OD mortality surveillance workflow will increase the specificity of drugs identified 
on OD DCs through fine-grained spotting, compared to both ICD-10 coding and other 
methods.7 Importantly, ongoing application of the NLP approach as part of the routine 
drug OD surveillance analysis will allow for the detection of novel substances as soon as 





substance names. Addition of a new substance to a lookup table depends on 
circumstances within a rapidly changing drug market, which can be demanding, as 
evidenced by the difference in performance between the two lookup table methods tested. 
Since the developed algorithm can utilize context, it has the ability to recognize novel 
drug entities without constant modification of the underlying model. The model’s ability 
to recognize novel entities will provide the opportunity for early warning signals for 
novel substances, and thus faster public health and public safety response. Additionally, 
the increased granularity will provide an overall improvement in surveillance data 
quality, which will lead to more accurate reporting of information to communities and 
stakeholders. The proposed neural NER methods expand our previous work on DC free-
text41 where we developed a NLP algorithm to capture drug OD death cases prior to ICD-
10 coding. In combination, the two NLP algorithms can be added to the routine drug OD 
mortality surveillance tools to improve the early identification of drug OD deaths and 




Future studies should apply the developed model to data from other jurisdictions 
and assess the model’s performance to explore generalizability of the model. This 
generalizability would indicate that the model can be directly integrated into the 
surveillance work of other states and localities without the need for annotation and 
training. Additionally, future research should utilize a similar workflow for identifying 





model, due to the nature of DC free-text, would achieve high scores on other free-text 
OD surveillance sources such as emergency medical services run data, future studies 
should explore the use of the Flair library and particularly pooled Flair embeddings for 
drug NER tasks. One limitation of the lookup table approach for identification of drugs 
involved in fatal ODs is the lack of context analysis. For example, if “history of heroin 
abuse” was mentioned on a drug OD death certificate, the lookup table approach as well 
as our currently proposed NLP algorithm would identify the OD death as heroin-
involved. Since NLP methods can be trained to recognize context, a future improvement 
of our NLP algorithm would be the filtering out of the drug entities in situations where 
the drugs were not mentioned as contributory to the OD death. This specific scenario did 
not occur frequently in Kentucky data used to develop the model, but will be an 
important improvement to avoid false positive cases for drug OD involvement of specific 
drugs. 
 
Strengths and limitations 
The developed method has several strengths. First, the developed dataset 
consisted of a large sample (n=8,146) of OD DCs spanning multiple years of data. The 
dataset was annotated by 4 trained annotators, ensuring accurate labels were produced 
which was verified by a high overall kappa statistic (0.983). Another strength of the 
method was the way in which the train-validation-test split was performed. By using 
earlier records for training and validation, and testing on later DCs, the model 
demonstrated that it can use older data to produce accurate predictions on new data, 





high F-score (99.13%) achieved, displaying high accuracy for identifying drug entities on 
free-text DCs. 
The study does have a few limitations. A primary limitation is that the developed 
NER model cannot be used as a stand-alone surveillance tool; rather, it should be 
implemented as an enhancement in current OD mortality surveillance work to improve 
drug identification on death certificates. The lookup table-based methods contain 
crosswalks of drug search terms to their parent drug (for example, misspelling 
“CLONAZPAM” is cross-walked to parent drug “CLONAZEPAM”). Since the NER 
method, by design, recognizes novel entities, these entities are not present in dictionaries 
and their respective crosswalks, and therefore the NER model cannot be used as a 
surveillance tool alone. This limitation is addressed, however, by utilizing the model 
periodically on new data to recognize novel entities and adding these entities to existing 
lookup tables, so that novel entities can be identified by surveillance tools. Further, the 
inclusion of an entity in a lookup table guarantees that it will be recognized on every 
record it appears in, regardless of context—this addresses the rarely occurring scenario 
when a drug entity was not identified by the NER model due to it appearing in different 
context than the model learned. 
An additional limitation is that the entirety of the data used for training the model 
came from Kentucky DCs. The performance of the model on data from other jurisdictions 
should be evaluated. Additionally, the comparison of model performance to performance 
of the lookup table method is conditional on how up-to-date a given lookup table is; other 
jurisdictions may have more complete tables, so the performance improvement from the 





complexity of the method and the need for computationally powerful hardware when 
applied to large datasets. Finally, the complexity of the model makes diagnosing errors 
difficult, which is an inherent limitation in most ML applications. 
 
Conclusion 
To our knowledge, this study is the first of its kind to use deep neural networks 
for drug NER on DCs. The highest performing model developed achieved an F-score of 
99.13%, indicating that the method is highly accurate at this task. The high performance 
of the developed model clearly shows that deep learning models should be integrated into 
public health surveillance workflows. Particularly for drug OD mortality surveillance, the 
method could improve surveillance data quality and timeliness, enabling public health 
practitioners to more quickly recognize novel substances and more accurately report data 
to communities. The developed method advances the science of public health 
surveillance by integrating NLP models not currently used in the field into surveillance 
workflows and advance public health practice through enhancing both data quality and 
timeliness of reporting. These surveillance improvements are key in monitoring the 































































Table 10: Performance of machine learning models on test set 
Method 
Tested 




PPV Sensitivity F-score 
GloVe 3168 44 62 98.63% 98.08% 98.35% 
Pooled Flair 3201 27 29 99.16% 99.10% 99.13% 
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Table 11: Example Classified Death Certificate Records  
Death certificate tokens1 Recognized by the 
lookup table 
Recognized by NER 
model2 
ACUTE   
INTOXICATION   
BY   
THE   
COMBINED   
EFFECTS   
OF   
FENTANYL   
,   
ACETYLFENTANYL   
,   
METHAMPHETTAMINE   
,   
TRAMADOL   
,   
AND   
GABAPENTIN   
SUBSTANCE   
ABUSE   
MULTIPLE   
DRUG   
INTOXICATION   
(   
METHAMPHETIMINE   
,   
CLONAZAPAM   
,   
OXYCODONE   
,   
GABAPENTIN   
)   
MULTIPLE   
DRUG   
INTOXICATION   
ACUTE   
COMBINED   
TOXIC   
EFFECTS   





[   
METHAMPHETAMINE   
,   
FENTANYL   
,   
HEROIN   
,   
GABAPENTIN   
,   
&   
PARAFLUOROBUTYRYLFENTANYL   
]   
SELF   
ADMINISTRATION   
OF   
ILLICIT   
DRUGS   



















Discussion and Conclusions 
This dissertation sought to advance surveillance science and public health practice 
through examining and testing the integration of natural language processing (NLP) and 
machine learning (ML) methods into the drug overdose mortality surveillance workflow. 
A thorough review of the literature found that NLP and ML methods, particularly deep 
learning models, are used scarcely in public health surveillance. However, evidence from 
clinical sciences18,19 indicates that there is untapped potential for NLP and ML methods 
to enhance public health surveillance activities. Applying NLP methods into surveillance 
advances science through the tenets of integration and development24, by leveraging 
techniques used primarily in other disciplines to improve understanding and stimulating 
additional research in the field, respectively. The dissertation focused on advancing 
surveillance practice in drug overdose mortality surveillance in particular as overdose 
mortality is one of the most pressing public health crises the United States has faced in 
recent history,4 with the age-adjusted drug overdose death rate increasing from 20.7 per 
100,000 people in 2018 to 21.6 per 100,000 people in 20191. This dissertation presents 
the development and application of two NLP models that improve drug overdose 
mortality surveillance timeliness and data quality.  
Enhancing timeliness 
 A primary limitation of drug overdose mortality surveillance is the timeliness of 
the data.97 Drug overdose mortality surveillance relies on death certificates, which 
become available to state and local epidemiologists after a substantial time lag 





National Center for Health Statistics (NCHS). Delays in obtaining data limit the ability of 
practitioners to disseminate surveillance data to stakeholders as well as prohibiting timely 
responses to increases in drug overdose mortality. To improve drug overdose mortality 
data timeliness, Chapters 3 and 4 developed classification and named entity recognition 
(NER) models, respectively, that can analyze free-text death certificate data. The 
developed methods eliminate the time required to transfer death certificates between the 
state Office of Vital Statistics (OVS) and the NCHS and the time for NCHS to add 
International Classification of Diseases, 10th Edition16 (ICD-10) codes to the death 
certificate. Utilization of the developed models in tandem to enhance currently existing 
surveillance tools allows for full-scale drug overdose mortality surveillance—both case 
identification and identification of drugs that caused the death—prior to ICD-10 coding. 
 Pre-processing of death certificates using the model developed in Chapter 3 while 
records undergo ICD-10 coding allows public health practitioners to obtain provisional 
counts of overdose deaths more quickly. Faster data can lead to quicker implementation 
of harm reduction strategies, such as targeted naloxone distribution, thereby advancing 
public health practice. Enhancing the timeliness of data through NLP also reflects an 
improvement in the science of surveillance as well. According to the National Research 
Council, two of the five ways in which science can be advanced is by integration (e.g., 
linking insights and methodologies from other fields and levels of analysis) and 
development (e.g., stimulating additional research in the field)24. This dissertation 
accomplishes both by integrating methodologies from other disciplines into public health 
surveillance and by developing a base on which future scientists can build to add further 





Enhancing data quality 
 In addition to timeliness, drug overdose mortality surveillance is also limited by 
weaknesses in data quality. Death certificate data is the only national source for overdose 
mortality surveillance,5 and is the primary source for state and local mortality 
surveillance, making the quality of the data essential so that jurisdictions can provide 
accurate information to communities, promote appropriate evidence-based practices and 
policies, and monitor the impact of interventions and changes in policy. A primary data 
quality limitation in drug overdose mortality surveillance is the coarse granularity of 
information on what substances caused death (e.g., ICD-10 code indicates T43.6, 
“psychostimulants with abuse potential” as the substance, when the specific substance 
involved was methamphetamine). To address this challenge in data quality, the method 
presented in Chapter 4 leverages NLP to identify novel drugs and/or drug misspellings 
currently absent from lookup tables used to determine drugs involved in overdose deaths. 
 Chapter 4 focused on developing a state-of-the art method for identifying drug 
mentions on free-text death certificate data. The developed deep learning model was able 
to identify novel drugs and misspellings that look-up tables traditionally used for 
performing overdose mortality surveillance were unable to identify. The developed 
method improves surveillance data quality by identifying novel drugs and misspellings 
on free-text death certificates that are not present in current lookup tables. These new 
entities can be added to the lookup tables of existing surveillance tools. 
 Adding novel entities identified by the model to the lookup tables of current 
surveillance tools will improve the identification of drugs on the death certificate. The 





that are not present in the tables currently used. This improved identification ensures that 
jurisdictions are responding to the specific drugs that are causing morbidity and mortality 
in a community. Many jurisdictions will not have the expertise nor the computational 
power to develop and apply NLP models. Therefore, it will be necessary for centers with 
the expertise to periodical run the developed deep learning model on new death 
certificates, add novel entities to lookup tables, and disseminate the updated lookup tables 
to jurisdictions. This process will provide increased specificity of detecting drug entities 
without the need for each jurisdiction to run a complex model. 
 As public health initiatives rely on surveillance data, ensuring that the data is as 
accurate as possible is essential. The enhancement of surveillance data quality through 
the implementation of NLP methods advances public health practice by ensuring that 
decisions are made on accurate, high quality data. Additionally, surveillance science is 
advanced by integration (by applying techniques that emerged from a different field, 
linked to previous work in clinical sciences).24 Applying NLP methods into surveillance 
science are a necessity as unstructured, free-text data sources have become common in 
epidemiological surveillance44,45 and the methods developed for death certificates in the 
present dissertation show promise for utilization of NLP on other sources, further 
advancing surveillance science through the tenet of development.24 
Limitations 
 The contribution of this dissertation to practice and science should be interpreted 
in light of its limitations. Despite the promise for NLP methods described in the narrative 
review, adoption of these methods into surveillance workflows may not be possible in all 





not have the expertise or computing infrastructure needed to implement NLP and ML 
models, including those discussed in Chapters 3 and 4, in their work. However, even in 
these contexts, the NER model from Chapter 4 has value. NER can be used to identify 
new drug entities that can be added to look-up tables that those working in public health 
currently use, allowing them to detect novel substances and identify misspellings that 
were previously missing. Integrating the model presented in Chapter 4 as a tool to 
improve existing drug dictionaries addresses another limitation of this method, as its use 
as a stand-alone surveillance tool is limited since the entities the tool identifies must be 
manually linked to a parent drug. Adding novel entities to a lookup table, which typically 
contain crosswalks to parent drugs, addresses this limitation. 
 Another limitation is that the methods developed were trained using only data 
from Kentucky death certificates. While Kentucky has a robust drug overdose mortality 
surveillance system,32 thereby boosting the rigor of the analyses, it remains unknown 
whether models will be generalizable outside of Kentucky. Death certificate free-text is 
typically short and direct, so it is unlikely that the language used on other jurisdictions’ 
death certificates would differ substantially. A final limitation is the inability to diagnose 
errors in the models’ performance. Complex ML models suffer from the “black box” 
problem,133 which makes identifying why the model incorrectly predicted a response 
difficult due to the large number of inputs and interactions present in the underlying 
model. 
Future research 
 This dissertation highlights the ability of NLP and ML models to advance public 





mortality surveillance. The narrative review showed that despite widespread use in 
clinical sciences there was limited use of NLP methods in public health surveillance, 
despite data sources including free-text elements.20 An additional gap in the use of NLP 
methods in public health was the lack of state-of-the-art models used, indicating that 
current advances in NLP science had not yet been translated to public health practice. 
Implementing deep learning approaches in surveillance, as Chapter 4 of the dissertation 
demonstrates, will improve surveillance data quality and increase case identification.  
 Future research in the field of drug overdose mortality surveillance should test the 
developed models and develop new models on data from additional jurisdictions. 
Demonstrating that the current models can accurately predict labels on data from other 
jurisdictions or training a new model on data from several jurisdictions would eliminate 
the current limitation of having data from only one state present. The latter would also 
increase the sample size used to train the model, which typically will improve model 
performance and lead to a more accurate model overall. Additionally, further 
improvements can be made to the methods developed in Chapters 3 and 4. Additional 
feature engineering, such as non-sequential tokens, could be explored to improve the 
classification model developed in Chapter 3. The model developed in Chapter 4 could be 
improved to learn additional context so that it does not identify drug entities appearing in 
phrases such as “history of heroin abuse” which are not indicative that the drug was 
involved in the overdose death. 
 Finally, there are other surveillance data sources currently used for drug overdose 
mortality surveillance that contain free-text data, including emergency medical services 





investigate the use of NLP, specifically the Flair124 library used in Chapter 4, as a tool for 
information extraction and classification of these data sources. Adding NLP and ML to 
the surveillance workflow for these sources will improve the quality of drug overdose 
morbidity surveillance in a similar manner to how this dissertation improves the quality 
of drug overdose mortality surveillance. 
Conclusion 
 The work of the present dissertation advances the current state of surveillance 
science and public health practice through the integration of NLP and ML methods that 
are not currently used in the field. Integrating NLP and ML methods into the surveillance 
pipeline enhances both the timeliness and quality of drug overdose mortality surveillance 
data. Timely, accurate data is essential to monitoring the ongoing drug overdose 
epidemic, as it ensures public health and public safety resources are directed at the 
substances currently causing morbidity and mortality in communities. 
 The methods developed had high scores for positive predictive value, sensitivity, 
and F-score. In particular, the sensitivity of the NLP methods was substantially higher 
than those of currently used surveillance tools. This improved sensitivity leads to a low 
false negative rate, meaning more cases that meet case criteria are identified than the 
currently used text-matching methods and look-up tables. Increased case identification 
allows for the collection of additional data sources in a timelier manner which can 
improve the public health response to increases in overdose mortality. 
 NLP and ML methods are under-utilized in public health surveillance overall. 
Implementation of these tools are necessary as the data collected for surveillance 





data is important to ensure that the public health response is based on the best available 
evidence. This dissertation shows that integrating NLP and ML methods into a 
surveillance workflow can lead to enhancements in both data timeliness and data quality 
and provides an overall advancement to public health practice and surveillance science 
through the development of two highly accurate models that ensure timely, high quality 























Appendix 1: Phrase list for rule-based method 
1. Overdose 
2. Polypharmacy 
3. Drug intoxication 
4. Multiple drug 
5. Combined drug 
6. Acute combined 
7. Intoxication drug 
8. Drug toxicity 
9. Acute fentanyl 
10. Fentanyl intoxication 
11. Fentanyl toxicity 
12. Heroin intoxication 
13. Multidrug intoxication 
14. Heroin toxicity 
15. Acute intoxication 
16. Combined effects 
17. Toxic effects 
18. Acute heroin 
19. Multi drug 
20. Multiple drugs 
21. Illicit drugs 
22. Abused fatal 
23. Heroin fentanyl 
24. Intoxication fentanyl 
25. Fentanyl morphine 
26. Intoxication methamphetamine 
27. Acute multidrug 
28. Intoxication heroin 
29. Illicit drug 
30. Acute methamphetamine 
31. Drug fentanyl 
32. Drugs including 
33. Gabapentin drug 
34. Methamphetamine intoxication 
35. Intoxication overdose 
36. Drug heroin 








Appendix 2: Error analysis 
The false positives and false negatives of the SVM model excluding the SCC 
section were examined manually to determine if a post-processing step after the classifier 
is deployed could be used to improve classification. As Table 4 of the manuscript shows, 
this model had a total of 35 false positives and 21 false negatives on the test data. Of the 
35 false positives, more than 10 appear to be data quality errors in the UCOD field on the 
DC records. These cases have free-text that points to the death being an OD death, but the 
text listed in the UCOD field is not an ICD-10 code.  
Another category of the false positive cases are cases that appear to be OD deaths 
that were wrongly coded at NCHS. Of these cases, several of them mention the term 
“overdose” which likely lead the classifier to predict that these cases are ODs. Other 
cases in this category mention the decedent dying as a result of “drug intoxication” 
(listing a specific drug or indicating multiple drugs) or mention elevated levels of a 
substance in the decedent’s system. Interestingly, most of the cases in these categories list 
other complications, such as “asphyxiation due to drug overdose”, with NCHS then 
coding the cases as an asphyxiation death. However, if the OD was an event that directly 
caused the individual to asphyxiate, these deaths should perhaps be coded as OD deaths. 
This presents another use for this classifier—potentially identifying additional OD deaths 
that were miscoded at NCHS. 
The majority of the other false positives are cases that involve deaths caused by 
chronic drug abuse (not an acute OD event) or an OD exacerbating some sort of 





an individual overdosing and then falling into a river and drowning, or an individual 
ingesting drugs and aggravating their existing chronic obstructive pulmonary disease. 
The presence of specific words, such as substances and terms like “intoxication”, likely 
lead to the classifier mistaking these for OD deaths. 
Many of the 21 false negatives were cases with a small amount of text that 
contained substances that are rarely seen in OD deaths (such as acetaminophen) or 
contain misspellings. For example, one false negative misspells “toxicity” as “tocicity” 
and others misspell “drug” as “drue.” Employing an automated spell checker when 
preprocessing the text may fix some of these errors. The other false negatives are the 
opposite—well written text that is much longer than what typically appears on a DC. 
Many of these list that the decedent died from a combination of drugs and alcohol, so the 
presence of the word alcohol (or related terms such as ethanol) may signal the classifier 
















Appendix 3: Flair Modeling Code 
In [1]: 
# Reading in the corpus 
from flair.data import Corpus 
from flair.datasets import ColumnCorpus 
 
columns = {0: "text", 1: "ner"} 
data_folder = "/home/pjwa227/Corpus2/" 
 
corpus: Corpus = ColumnCorpus(data_folder, columns, 
                             train_file = "train.txt",  
                             test_file = "test.txt", 
                             dev_file = "val.txt") 
2020-12-11 09:17:50,035 Reading data from /home/pjwa227/Corpus2 
2020-12-11 09:17:50,036 Train: /home/pjwa227/Corpus2/train.txt 
2020-12-11 09:17:50,036 Dev: /home/pjwa227/Corpus2/val.txt 
2020-12-11 09:17:50,036 Test: /home/pjwa227/Corpus2/test.txt 
In [2]: 





INTRAVENTRICULAR HEMORRHAGE COUMADIN <S-DRUG> TOXICITY 
In [3]: 
# Tell flair what tag we want to predict 
tag_type = "ner" 
tag_dictionary = corpus.make_tag_dictionary(tag_type=tag_type) 
In [4]: 
# Load embeddings 
from flair.embeddings import PooledFlairEmbeddings, StackedEmbeddings 
 
embeddings : StackedEmbeddings = 
StackedEmbeddings([PooledFlairEmbeddings("news-forward"), 
                                                    
PooledFlairEmbeddings("news-backward"),]) 
In [5]: 
# Initialize the sequence tagger 
from flair.models import SequenceTagger 
 
tagger : SequenceTagger = SequenceTagger(hidden_size =256, 
                                         embeddings = embeddings, 
                                         tag_dictionary = 
tag_dictionary, 
                                         tag_type = tag_type, 







  (embeddings): StackedEmbeddings( 
    (list_embedding_0): PooledFlairEmbeddings( 
      (context_embeddings): FlairEmbeddings( 
        (lm): LanguageModel( 
          (drop): Dropout(p=0.05, inplace=False) 
          (encoder): Embedding(300, 100) 
          (rnn): LSTM(100, 2048) 
          (decoder): Linear(in_features=2048, out_features=300, 
bias=True) 
        ) 
      ) 
    ) 
    (list_embedding_1): PooledFlairEmbeddings( 
      (context_embeddings): FlairEmbeddings( 
        (lm): LanguageModel( 
          (drop): Dropout(p=0.05, inplace=False) 
          (encoder): Embedding(300, 100) 
          (rnn): LSTM(100, 2048) 
          (decoder): Linear(in_features=2048, out_features=300, 
bias=True) 
        ) 
      ) 
    ) 
  ) 
  (word_dropout): WordDropout(p=0.05) 
  (locked_dropout): LockedDropout(p=0.5) 
  (embedding2nn): Linear(in_features=8192, out_features=8192, 
bias=True) 
  (rnn): LSTM(8192, 256, batch_first=True, bidirectional=True) 
  (linear): Linear(in_features=512, out_features=8, bias=True) 
  (beta): 1.0 
  (weights): None 




from flair.trainers import ModelTrainer 
trainer : ModelTrainer = ModelTrainer(tagger, corpus) 
 
trainer.train('resources/taggers/pooled_flair_ner', 
              learning_rate=0.1, 
              mini_batch_size=32, 
              max_epochs=150) 
Results: 
- F1-score (micro) 0.9913 
- F1-score (macro) 0.9913 
 
By class: 
DRUG       tp: 3201 - fp: 27 - fn: 29 - precision: 0.9916 - recall: 
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Appendix 5: Drug entities present in test data not in Drug Overdose Fatality 
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